STOCK TITAN

[8-K] ETHZilla Corp Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

ETHZilla Corporation reported that stockholders approved several governance and financing actions at a Special Meeting held on October 7, 2025. Shareholders approved an amendment to the company's certificate of incorporation to increase authorized common shares from 1,000,000,000 to 5,000,000,000, and the company filed the Certificate of Amendment with the Delaware Secretary of State, which became effective on October 8, 2025. Stockholders also approved the issuance of shares underlying certain senior secured convertible notes issued under an August 8, 2025 Securities Purchase Agreement; the votes permit issuance in an amount that may equal or exceed 20% of common stock outstanding immediately prior to those issuances. Voting results for the listed proposals are included in the report and an exhibit (Exhibit 99.1) was furnished to the SEC.

ETHZilla Corporation ha riferito che gli azionisti hanno approvato diverse azioni di governance e finanziamento durante una riunione speciale tenutasi il 7 ottobre 2025. Gli azionisti hanno approvato una modifica dello statuto della società per aumentare le azioni ordinarie autorizzate da 1.000.000.000 a 5.000.000.000, e la società ha depositato il Certificate of Amendment presso il Delaware Secretary of State, che è diventato efficace l'8 ottobre 2025. Gli azionisti hanno inoltre approvato l'emissione di azioni a copertura di alcuni notes convertibili senior garantiti emessi ai sensi di un Securities Purchase Agreement del 8 agosto 2025; i voti autorizzano l'emissione in una quantità che può essere pari o superiore al 20% delle azioni ordinarie in circolazione immediatamente prima di tali emissioni. I risultati delle votazioni per le proposte elencate sono inclusi nel rapporto e un exhibit (Exhibit 99.1) è stato fornito alla SEC.

ETHZilla Corporation informó que los accionistas aprobaron varias acciones de gobernanza y financiamiento en una Reunión Especial celebrada el 7 de octubre de 2025. Los accionistas aprobaron una enmienda al certificado de constitución de la empresa para aumentar las acciones comunes autorizadas de 1,000,000,000 a 5,000,000,000, y la empresa presentó el Certificate of Amendment ante el Delaware Secretary of State, que entró en vigor el 8 de octubre de 2025. Los accionistas también aprobaron la emisión de acciones subyacentes a ciertas notas convertibles senior garantizadas emitidas en virtud de un Securities Purchase Agreement del 8 de agosto de 2025; los votos permiten la emisión en una cantidad que puede igualar o exceder al 20% de las acciones ordinarias en circulación inmediatamente antes de esas emisiones. Los resultados de votación para las propuestas listadas se incluyen en el informe y se adjuntó a la SEC un Exhibit (Exhibit 99.1).

ETHZilla Corporation은 특별 이사회에서 주주들이 거버넌스 및 재무 조치들을 승인했다고 보고했습니다. 이는 2025년 10월 7일에 개최된 특별회의에서 이루어졌습니다. 주주들은 회사의 정관을 수정하여 승인된 보통주를 1,000,000,000주에서 5,000,000,000주로 증가시키는 것을 승인했고, 회사는 수정 증서(Certificate of Amendment)를 델라웨어 주무관(Delaware Secretary of State)에 제출했으며 이는 2025년 10월 8일에 발효되었습니다. 또한 주주들은 2025년 8월 8일의 증권 매매 계약에 따라 발행된 특정 상위 담보 전환사채에 기초하는 주식의 발행을 승인했습니다. 이 의결은 그 발행이 그 직전에 유통 중인 보통주 수의 20%에 해당하거나 그를 초과할 수 있음을 허용합니다. 목록에 있는 제안에 대한 표결 결과는 보고서에 수록되었고 Exhibit 99.1(전시물)이 SEC에 제출되었습니다.

ETHZilla Corporation a annoncé que les actionnaires ont approuvé plusieurs mesures de gouvernance et de financement lors d'une assemblée extraordinaire tenue le 7 octobre 2025. Les actionnaires ont approuvé un amendement au certificat de constitution de la société pour augmenter le nombre d'actions ordinaires autorisées de 1 000 000 000 à 5 000 000 000, et la société a déposé le certificat d'amendement auprès du Delaware Secretary of State, qui est devenu effectif le 8 octobre 2025. Les actionnaires ont également approuvé l'émission d'actions sous-jacentes à certaines notes convertibles seniors garanties émises en vertu d'un Securities Purchase Agreement du 8 août 2025; les votes autorisent l'émission d'un montant qui peut équivaloir ou dépasser 20% des actions ordinaires en circulation immédiatement avant ces émissions. Les résultats du vote pour les propositions énumérées figurent dans le rapport et une exposition (Exhibit 99.1) a été fournie à la SEC.

ETHZilla Corporation berichtete, dass Aktionäre mehrere Governance- und Finanzierungsmaßnahmen bei einer Sondersitzung am 7. Oktober 2025 genehmigt haben. Die Aktionäre genehmigten eine Änderung der Satzung des Unternehmens, um die autorisierten Stammaktien von 1.000.000.000 auf 5.000.000.000 zu erhöhen, und das Unternehmen reichte das Certificate of Amendment beim Delaware Secretary of State ein, das am 8. Oktober 2025 in Kraft trat. Die Aktionäre genehmigten außerdem die Ausgabe von Aktien, die bestimmten senior gesicherten wandelbaren Anleihen entsprechen, die gemäß einer Securities Purchase Agreement vom 8. August 2025 ausgegeben wurden; Die Abstimmungsergebnisse erlauben eine Emission in einer Höhe, die gleich oder über 20% des unmittelbar vor diesen Emissionen ausstehenden Stammkapitals liegen kann. Die Abstimmungsergebnisse zu den aufgeführten Vorschlägen sind im Bericht enthalten, und ein Exhibit (Exhibit 99.1) wurde der SEC vorgelegt.

أبلغت ETHZilla Corporation أن المساهمين وافقوا على عدة إجراءات حوكمة وتمويل في اجتماع خاص عُقد في 7 أكتوبر 2025. وافق المساهمون على تعديل في شهادة تأسيس الشركة لزيادة عدد الأسهم العادية المصرح بها من 1,000,000,000 إلى 5,000,000,000, وقد قدمت الشركة شهادة التعديل إلى كاتب عدل ديلاوير، والتي أصبحت سارية المفعول في 8 أكتوبر 2025. كما وافق المساهمون على إصدار الأسهم الكامنة وراء بعض السندات القابلة للتحويل المضمونة من الدرجة العليا التي صدرت بموجب اتفاق شراء سندات بتاريخ 8 أغسطس 2025؛ تسمح الأصوات بالإصدار بمقدار يمكن أن يساوي أو يفوق 20% من رأس المال العادي القائم وقت الإصدار. نتائج التصويت على المقترحات المدرجة مذكورة في التقرير وتم تزويد SEC بعرض (Exhibit 99.1).

ETHZilla Corporation 报告称,股东在于 2025年10月7日举行的特别会议上通过了若干治理与融资措施。股东批准修改公司章程以将授权普通股从 1,000,000,000 股增至 5,000,000,000 股,公司向特拉华州务卿提交了修订证书(Certificate of Amendment),该证书于 2025年10月8日 生效。股东还批准按 2025年8月8日 的证券购买协议发行的若干高级有担保可转换票据所对应的股份的发行;该等投票允许发行量达或超过在发行前即时尚存的普通股的 20%。Listed proposals 的投票结果包含在报告中,并向 SEC 提交了一个展品(Exhibit 99.1)。

Positive
  • Shareholders approved amendment to increase authorized common shares from 1,000,000,000 to 5,000,000,000
  • Certificate of Amendment filed and effective with Delaware on October 8, 2025
  • Shareholders approved issuance of shares underlying senior secured convertible notes per the August 8, 2025 Securities Purchase Agreement
Negative
  • Potential dilution: approved issuances may equal or exceed 20% of pre-issuance outstanding common stock
  • Significant increase in authorized shares expands shares available for issuance, which may dilute existing holders if used broadly

Insights

Shareholder approval broadens share capacity and eases future equity transactions.

Increasing authorized common shares from 1,000,000,000 to 5,000,000,000 removes a legal cap that previously constrained the company from issuing additional equity without further charter amendments. This gives the board flexibility to issue shares for financing, acquisitions, compensation, or conversion events.

The main dependency is how the board uses the new authorization; issuing large blocks can dilute existing holders. Monitor any near-term registration statements, convertible note settlements, or equity-based compensation plans over the next 3–12 months.

Approved convertible-note issuances could meaningfully increase share count, up to or above 20%.

The approval covers issuance of shares underlying senior secured convertible notes issued under the August 8, 2025 Securities Purchase Agreement; the company disclosed the potential issuance could be equal to or exceed 20% of outstanding common stock measured before issuance. That is a material dilutive capacity tied to those financing instruments.

Watch for disclosure of conversion mechanics, exchange caps, and any registration or resale limitations within the next quarter, since those terms will determine the actual dilution and market impact.

ETHZilla Corporation ha riferito che gli azionisti hanno approvato diverse azioni di governance e finanziamento durante una riunione speciale tenutasi il 7 ottobre 2025. Gli azionisti hanno approvato una modifica dello statuto della società per aumentare le azioni ordinarie autorizzate da 1.000.000.000 a 5.000.000.000, e la società ha depositato il Certificate of Amendment presso il Delaware Secretary of State, che è diventato efficace l'8 ottobre 2025. Gli azionisti hanno inoltre approvato l'emissione di azioni a copertura di alcuni notes convertibili senior garantiti emessi ai sensi di un Securities Purchase Agreement del 8 agosto 2025; i voti autorizzano l'emissione in una quantità che può essere pari o superiore al 20% delle azioni ordinarie in circolazione immediatamente prima di tali emissioni. I risultati delle votazioni per le proposte elencate sono inclusi nel rapporto e un exhibit (Exhibit 99.1) è stato fornito alla SEC.

ETHZilla Corporation informó que los accionistas aprobaron varias acciones de gobernanza y financiamiento en una Reunión Especial celebrada el 7 de octubre de 2025. Los accionistas aprobaron una enmienda al certificado de constitución de la empresa para aumentar las acciones comunes autorizadas de 1,000,000,000 a 5,000,000,000, y la empresa presentó el Certificate of Amendment ante el Delaware Secretary of State, que entró en vigor el 8 de octubre de 2025. Los accionistas también aprobaron la emisión de acciones subyacentes a ciertas notas convertibles senior garantizadas emitidas en virtud de un Securities Purchase Agreement del 8 de agosto de 2025; los votos permiten la emisión en una cantidad que puede igualar o exceder al 20% de las acciones ordinarias en circulación inmediatamente antes de esas emisiones. Los resultados de votación para las propuestas listadas se incluyen en el informe y se adjuntó a la SEC un Exhibit (Exhibit 99.1).

ETHZilla Corporation은 특별 이사회에서 주주들이 거버넌스 및 재무 조치들을 승인했다고 보고했습니다. 이는 2025년 10월 7일에 개최된 특별회의에서 이루어졌습니다. 주주들은 회사의 정관을 수정하여 승인된 보통주를 1,000,000,000주에서 5,000,000,000주로 증가시키는 것을 승인했고, 회사는 수정 증서(Certificate of Amendment)를 델라웨어 주무관(Delaware Secretary of State)에 제출했으며 이는 2025년 10월 8일에 발효되었습니다. 또한 주주들은 2025년 8월 8일의 증권 매매 계약에 따라 발행된 특정 상위 담보 전환사채에 기초하는 주식의 발행을 승인했습니다. 이 의결은 그 발행이 그 직전에 유통 중인 보통주 수의 20%에 해당하거나 그를 초과할 수 있음을 허용합니다. 목록에 있는 제안에 대한 표결 결과는 보고서에 수록되었고 Exhibit 99.1(전시물)이 SEC에 제출되었습니다.

ETHZilla Corporation a annoncé que les actionnaires ont approuvé plusieurs mesures de gouvernance et de financement lors d'une assemblée extraordinaire tenue le 7 octobre 2025. Les actionnaires ont approuvé un amendement au certificat de constitution de la société pour augmenter le nombre d'actions ordinaires autorisées de 1 000 000 000 à 5 000 000 000, et la société a déposé le certificat d'amendement auprès du Delaware Secretary of State, qui est devenu effectif le 8 octobre 2025. Les actionnaires ont également approuvé l'émission d'actions sous-jacentes à certaines notes convertibles seniors garanties émises en vertu d'un Securities Purchase Agreement du 8 août 2025; les votes autorisent l'émission d'un montant qui peut équivaloir ou dépasser 20% des actions ordinaires en circulation immédiatement avant ces émissions. Les résultats du vote pour les propositions énumérées figurent dans le rapport et une exposition (Exhibit 99.1) a été fournie à la SEC.

ETHZilla Corporation berichtete, dass Aktionäre mehrere Governance- und Finanzierungsmaßnahmen bei einer Sondersitzung am 7. Oktober 2025 genehmigt haben. Die Aktionäre genehmigten eine Änderung der Satzung des Unternehmens, um die autorisierten Stammaktien von 1.000.000.000 auf 5.000.000.000 zu erhöhen, und das Unternehmen reichte das Certificate of Amendment beim Delaware Secretary of State ein, das am 8. Oktober 2025 in Kraft trat. Die Aktionäre genehmigten außerdem die Ausgabe von Aktien, die bestimmten senior gesicherten wandelbaren Anleihen entsprechen, die gemäß einer Securities Purchase Agreement vom 8. August 2025 ausgegeben wurden; Die Abstimmungsergebnisse erlauben eine Emission in einer Höhe, die gleich oder über 20% des unmittelbar vor diesen Emissionen ausstehenden Stammkapitals liegen kann. Die Abstimmungsergebnisse zu den aufgeführten Vorschlägen sind im Bericht enthalten, und ein Exhibit (Exhibit 99.1) wurde der SEC vorgelegt.

false --12-31 0001690080 0001690080 2025-10-07 2025-10-07 0001690080 ETHZ:CommonStockParValue0.0001PerShareMember 2025-10-07 2025-10-07 0001690080 ETHZ:WarrantsToPurchaseSharesOfCommonStockMember 2025-10-07 2025-10-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): October 7, 2025

 

ETHZilla Corporation

(Exact Name of Registrant as Specified in Charter)

 

Delaware   001-38105   90-1890354
(State or Other Jurisdiction
of Incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

2875 South Ocean BlvdSuite 200

Palm BeachFL

  33480
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (650507-0669

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   ETHZ   The NASDAQ Stock Market LLC
Warrants to purchase shares of Common Stock   ETHZW   The NASDAQ Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 

 

 

 

Item 3.03 Material Modification to Rights of Security Holders.

 

The disclosures set forth in Item 5.03 of this Current Report on Form 8-K are incorporated into this Item 3.03 by reference.

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

The disclosures set forth in Item 5.07 of this Current Report on Form 8-K are incorporated into this Item 5.02 by reference. 

 

On October 7, 2025, at the Special Meeting (the “Special Meeting”) of the stockholders of the ETHZilla Corporation (the “Company”, “we” and “us”), the stockholders of the Company approved:

 

1.The adoption of the ETHZilla Corporation 2025 Omnibus Incentive Plan (the “Omnibus Plan”);

 

2.The adoption of the ETHZilla Corporation 2025 Supplemental Option Incentive Plan (the “2025 Supplemental Plan”); and

 

3.The adoption of the ETHZilla Corporation 2025 Second Supplemental Option Incentive Plan (the “Second 2025 Supplemental Plan”, and collectively with the 2025 Supplemental Plan and Omnibus Plan, the “Plans”),

 

in accordance with the voting results set forth below under Item 5.07.

 

The material terms of the Omnibus Plan, 2025 Supplemental Plan, and the Second 2025 Supplemental Plan, were described in the Company’s Definitive Proxy Statement on Schedule 14A (the “Proxy Statement”) filed with the Securities and Exchange Commission (SEC) on September 5, 2025, under “Proposal 2 Adoption of the ETHZilla Corporation 2025 Omnibus Incentive Plan”, “Proposal 3 Approval of the ETHZilla Corporation 2025 Supplemental Option Incentive Plan”, and “Proposal 4 Approval of the ETHZilla Corporation 2025 Second Supplemental Option Incentive Plan”, respectively.

 

ETHZilla Corporation 2025 Omnibus Incentive Plan

 

On August 26, 2025, the Board of Directors of the Company (the “Board”), with the recommendation of the Compensation Committee of the Board, adopted the Omnibus Plan, subject to stockholder approval at the Special Meeting.

 

The Company’s 2022 Omnibus Incentive Plan, as amended and restated (the “Prior Plan”), was originally adopted by the Board on April 26, 2022. As a result of the approval by the stockholders of the Omnibus Plan, no further shares will be granted as awards under the Prior Plan, the remaining shares reserved under the Prior Plan will be cancelled and the annual “evergreen” increases under the Prior Plan will stop.

 

The Omnibus Plan provides an opportunity for any employee, officer, director or consultant of the Company, subject to the terms of the Omnibus Plan, to receive (i) incentive stock options (to eligible employees only); or (ii) nonqualified stock options. Incentive stock options granted under the Omnibus Plan are intended to qualify as “incentive stock options” within the meaning of Section 422 of the Internal Revenue Code (the “Code”). Nonqualified (non-statutory stock options) granted under the Omnibus Plan are not intended to qualify as incentive stock options under the Code.

 

Subject to adjustment in connection with the payment of a stock dividend, a stock split or subdivision or combination of the shares of common stock, or a reorganization or reclassification of the Company’s common stock, upon approval of the Omnibus Plan, the aggregate number of shares of common stock which may be issued pursuant to awards under the Omnibus Plan shall initially equal 50,000,000 shares, and will automatically increase on April 1st of each year for a period of ten years commencing on January 1, 2026 and ending on (and including) January 1, 2035, in an amount equal to ten percent (10%) of the total shares of Company common stock outstanding on the last day of the immediately preceding fiscal year (the “Evergreen Measurement Date”); provided, however, that the Board may act prior to January 1st of a given year to provide that the increase for such year will be a lesser number of shares of common stock. No more than 5 billion shares may be awarded under the plan upon exercise of incentive stock options.

 

Awards under the Omnibus Plan may be made in the form of performance awards, restricted stock, restricted stock units, stock options, which may be either incentive stock options or non-qualified stock options, stock appreciation rights, other stock-based awards and dividend equivalents. Awards are generally non-transferable.

 

1

 

2025 Supplemental Option Incentive Plan

 

On July 29, 2025, the Board, with the recommendation of the Compensation Committee of the Board, adopted the 2025 Supplemental Plan. The 2025 Supplemental Plan was adopted, in accordance with the rules of The Nasdaq Capital Market, which allow the Company to adopt an equity arrangement and grant options thereunder prior to obtaining stockholder approval, provided that (i) no options can be exercised prior to obtaining stockholder approval, and (ii) the plan can be unwound, and the outstanding options cancelled, if stockholder approval is not obtained.

 

The 2025 Supplemental Plan provides an opportunity for any employee, officer, director or consultant of the Company, subject to the terms of the 2025 Supplemental Plan, to receive (i) incentive stock options (to eligible employees only); or (ii) nonqualified stock options. Incentive stock options granted under the 2025 Supplemental Plan are intended to qualify as “incentive stock options” within the meaning of Section 422 of the Code. Nonqualified (non-statutory stock options) granted under the 2025 Supplemental Plan are not intended to qualify as incentive stock options under the Code.

 

A total of 9,197,614 shares of common stock were reserved for awards under the 2025 Supplemental Plan, which awards have been fully granted to date.

 

2025 Second Supplemental Option Incentive Plan

 

On August 8, 2025, the Board, with the recommendation of the Compensation Committee of the Board, adopted the 2025 Second Supplemental Option Incentive Plan. The 2025 Second Supplemental Plan was adopted, in accordance with the rules of The Nasdaq Capital Market, which allow the Company to adopt an equity arrangement and grant options thereunder prior to obtaining stockholder approval, provided that (i) no options can be exercised prior to obtaining stockholder approval, and (ii) the plan can be unwound, and the outstanding options cancelled, if stockholder approval is not obtained.

 

A total of 1,814,221 shares of common stock were reserved for awards under the Second 2025 Supplemental Plan, which awards have been fully granted to date.

 

* * * * *

 

The above description of the Omnibus Plan, 2025 Supplemental Plan, and Second 2025 Supplemental Plan do not purport to be complete, and are qualified in their entirety by reference to the full text of the Omnibus Plan, 2025 Supplemental Plan, and Second 2025 Supplemental Plan which are filed herein or incorporated by reference herein, as Exhibits 10.1, 10.2, and 10.3, respectively, and are incorporated by reference into this Item 5.02 in their entirety by reference.

 

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. 

 

Increase in Authorized Shares

 

As discussed in greater detail in Item 5.07 and “Proposal 6 Approval of an Amendment to Our Second Amended and Restated Certificate of Incorporation to Increase the Company’s Authorized Number of Shares of Common Stock From One Billion (1,000,000,000) to Five Billion (5,000,000,000)” of the Proxy Statement, on October 7, 2025, at the Special Meeting, the stockholders of the Company approved an amendment to the Company’s Second Amended and Restated Certificate of Incorporation, to increase the Company’s authorized number of shares of common stock, par value $0.0001 per share from one billion (1,000,000,000) shares to five billion (5,000,000,000) shares.

 

On October 8, 2025, we filed a Certificate of Amendment to our Second Amended and Restated Certificate of Incorporation, as amended (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to increase the Company’s authorized number of shares of common stock, par value $0.0001 per share from one billion (1,000,000,000) shares to five billion (5,000,000,000) shares, which became effective when filed on October 8, 2025.

 

The foregoing description of the Certificate of Amendment does not purport to be complete and is qualified in its entirety by reference to the Certificate of Amendment attached hereto as Exhibit 3.1 and incorporated by reference herein.

 

2

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

At the Special Meeting, stockholders representing 58,122,938 shares of the Company’s capital stock entitled to vote at the Special Meeting were present in person or by proxy representing 35.34% of the voting shares issued and outstanding on the record date of August 20, 2025, and constituting a quorum to conduct business at the Special Meeting. The following sets forth the matters that were voted upon by the Company’s stockholders at the Special Meeting and the voting results for such matters. These matters are described in more detail in the Proxy Statement.

 

Proposal 1

 

The one individual listed below was elected at the Special Meeting to serve as a Class II director of the Company, to serve a term of one year and until his respective successor has been elected and qualified, or until such director’s resignation or removal, by the following vote:

 

Director Nominee   For   Withheld   Broker Non-Votes
Jason New   58,035,021   87,917  

 

Mr. New’s biographical information and the other information required by Items 401(b), (d), (e) and Item 404(a) of Regulation S-K are described in greater detail in the Proxy Statement under “Proposal 1 Election of Directors”.

 

No stockholders abstained from voting on the appointment of the director of the Company as discussed above.

 

Proposal 2

 

A management proposal to approve the adoption of the ETHZilla Corporation 2025 Omnibus Incentive Plan, was approved by the following vote:

 

For   Against   Abstain   Broker Non-Votes
57,809,800   267,242   45,596  

 

Proposal 3

 

A management proposal to approve the adoption of the ETHZilla Corporation 2025 Supplemental Option Incentive Plan, was approved by the following vote:

 

For   Against   Abstain   Broker Non-Votes
57,805,666   268,470   48,802  

  

Proposal 4

 

A management proposal to approve the adoption of the ETHZilla Corporation 2025 Second Supplemental Option Incentive Plan was approved by the following vote:

 

For   Against   Abstain   Broker Non-Votes
57,801,394   272,860   48,684  

 

3

 

Proposal 5

 

A management proposal to approve for purposes of complying with Section 5635(d) of the Listing Rules (the “Nasdaq Listing Rules”) of the Nasdaq Stock Market LLC as described in the Proxy Statement, the issuance of shares of the Company’s common stock underlying certain senior secured convertible notes issued by us pursuant to the terms of that certain Securities Purchase Agreement, dated August 8, 2025, between the Company and the investors named therein (the “Convertible Notes”), without giving effect to the exchange cap in such Convertible Notes in an amount that may be equal to or exceed 20% of our common stock outstanding immediately prior to the issuance of such Convertible Notes, was approved by the following vote:

 

For   Against   Abstain   Broker Non-Votes
57,968,712   135,489   18,737  

  

Proposal 6

 

A management proposal to approve an amendment to the Company’s Second Amended and Restated Certificate of Incorporation to increase the Company’s authorized number of shares of common stock, par value $0.0001 per share from one billion (1,000,000,000) shares to five billion (5,000,000,000) shares, was approved by the following vote:

 

For   Against   Abstain   Broker Non-Votes
57,921,498   185,460   15,980  

 

The Company plans to file the Certificate of Amendment to increase the Company’s authorized shares of common stock in the next few days and will file a Current Report on Form 8-K once filed.

 

Proposal 7

 

A management proposal to approve amendments to the Company’s Second Amended and Restated Certificate of Incorporation to remove obsolete provisions and make certain other clarifying, technical and conforming changes, was not approved by the following vote as the affirmative vote of at least a majority of the voting power of the outstanding stock entitled to vote on such proposal was not obtained, and stockholders of the Company voted on such proposals as follows:

 

For   Against   Abstain   Broker Non-Votes
57,991,571   104,706   26,661  

 

Proposal 8

 

A management proposal to approve an adjournment of the Special Meeting, if necessary, to solicit additional proxies if there was not sufficient votes at the time of the Special Meeting to approve any of the proposals to be voted upon at the Special Meeting, was approved, provided that the Company determined not to adjourn the Special Meeting:

 

For   Against   Abstain   Broker Non-Votes
57,980,954   107,385   34,599  

 

Item 7.01 Regulation FD Disclosure.

 

On October 8, 2025, the Company filed a press release announcing the appointment of Jason New as a member of the Board of Directors of the Company. A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference.

 

The information in this Item 7.01 of this Current Report on Form 8-K, including the information contained in Exhibit 99.1 is being furnished to the Securities and Exchange Commission, and shall not be deemed to be “filed” for the purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act of 1934, as amended, except as shall be expressly set forth by a specific reference in such filing.

 

4

 

Item 8.01. Other Events

 

The information provided in Item 5.07 is hereby incorporated by reference.

 

As a result of the approval of Proposal No. 3 above, the outstanding options to purchase 9,197,614 shares of common stock with an exercise price of $2.92 per share and cashless exercise rights, are now exercisable during the term of such options.

 

As a result of the approval of Proposal No. 4 above, outstanding options to purchase up to 1,814,221 shares of common stock with an exercise price of $3.01 per share and cashless exercise rights, are now exercisable during the term of such options.

 

As a result of the approval of Proposal No. 5 above, the principal amount of Convertible Notes is convertible into 51,229,508 shares of common stock, subject to further adjustment as provided therein, based on a current conversion price of $3.05 per share.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
3.1*   Certificate of Amendment of Second Amended and Restated Certificate of Incorporation for ETHZilla Corporation increasing the Company’s Authorized Number of Shares of Common Stock From One Billion (1,000,000,000) to Five Billion (5,000,000,000), as filed with the Secretary of State of Delaware on October 8, 2025
10.1*   ETHZilla Corporation 2025 Omnibus Incentive Plan
10.2   ETHZilla Corporation 2025 Supplemental Option Incentive Plan (filed as Exhibit 10.4 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on July 30, 2025, and incorporated by reference herein)
10.3   ETHZilla Corporation 2025 Second Supplemental Option Incentive Plan (filed as Exhibit 10.6 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 11, 2025, and incorporated by reference herein)
99.1**   Press Release of ETHZilla Corporation dated October 8, 2025
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

*Filed herewith.
**Furnished herewith.

 

5

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ETHZILLA CORPORATION
     
Date: October 8, 2025 By:  /s/ McAndrew Rudisill
    McAndrew Rudisill
    Chief Executive Officer

 

 

6

 

FAQ

What change to authorized shares did ETHZ (ETHZilla) approve?

Stockholders approved increasing authorized common stock from 1,000,000,000 to 5,000,000,000 and the Certificate of Amendment became effective on October 8, 2025.

Does the filing allow issuance of shares for convertible notes?

Yes. The vote approved issuance of shares underlying senior secured convertible notes issued under the August 8, 2025 Securities Purchase Agreement.

How large could the convertible-note-related issuance be?

The company disclosed the issuance could be equal to or exceed 20% of common stock outstanding immediately prior to such issuances.

When did the shareholder approvals occur?

Approvals were obtained at a Special Meeting held on October 7, 2025, with the amendment filing effective on October 8, 2025.

Where can I find the detailed voting results and exhibits?

Voting tallies and related information are included in the report; Exhibit 99.1 was furnished to the SEC and is incorporated by reference.
ETHZilla Corporation

NASDAQ:ETHZ

ETHZ Rankings

ETHZ Latest News

ETHZ Latest SEC Filings

ETHZ Stock Data

350.79M
138.35M
13.28%
6.94%
0.66%
Biotechnology
Pharmaceutical Preparations
Link
United States
PALO ALTO